GSTM1 and chronic kidney disease: A trend was observed for lower EQ-5D-3 L utility index and VAS scores, indicating poorer health status, to be reported at more advanced CKD stages and by patients with lower Hb levels across all CKD stages (Fig. 1), although patient numbers at more advanced CKD stage and lower Hb levels were low.